On Tuesday, Tango Therapeutics Inc (NASDAQ: TNGX) was 1.02% up from the session before settling in for the closing price of $6.84. A 52-week range for TNGX has been $6.32 – $13.01.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 132.62% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at -22.90%. With a float of $57.71 million, this company’s outstanding shares have now reached $102.20 million.
In an organization with 140 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 94.15%, operating margin of -311.57%, and the pretax margin is -273.63%.
Tango Therapeutics Inc (TNGX) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Tango Therapeutics Inc stocks. The insider ownership of Tango Therapeutics Inc is 46.14%, while institutional ownership is 56.77%. The most recent insider transaction that took place on Sep 13 ’24, was worth 709,756. In this transaction 10% Owner of this company sold 67,400 shares at a rate of $10.53, taking the stock ownership to the 16,859,075 shares. Before that another transaction happened on Sep 13 ’24, when Company’s Affiliate proposed sale 67,400 for $10.50, making the entire transaction worth $707,700.
Tango Therapeutics Inc (TNGX) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 6/30/2024, it has been observed that the corporation posted -0.23 earnings per share (EPS) during the time that was better than consensus figure (set at -0.34) by 0.11. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.38 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -22.90% per share during the next fiscal year.
Tango Therapeutics Inc (NASDAQ: TNGX) Trading Performance Indicators
You can see what Tango Therapeutics Inc (TNGX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 7.49. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 17.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.13, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.46 in one year’s time.
Technical Analysis of Tango Therapeutics Inc (TNGX)
Let’s dig in a bit further. During the last 5-days, its volume was 0.81 million. That was better than the volume of 0.75 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 51.37%. Additionally, its Average True Range was 0.52.
During the past 100 days, Tango Therapeutics Inc’s (TNGX) raw stochastic average was set at 10.20%, which indicates a significant decrease from 39.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 41.37% in the past 14 days, which was lower than the 74.45% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.02, while its 200-day Moving Average is $9.19. However, in the short run, Tango Therapeutics Inc’s stock first resistance to watch stands at $7.03. Second resistance stands at $7.16. The third major resistance level sits at $7.30. If the price goes on to break the first support level at $6.77, it is likely to go to the next support level at $6.63. The third support level lies at $6.51 if the price breaches the second support level.
Tango Therapeutics Inc (NASDAQ: TNGX) Key Stats
There are 106,846K outstanding shares of the company, which has a market capitalization of 740.34 million. As of now, sales total 36,530 K while income totals -101,740 K. Its latest quarter income was 19,880 K while its last quarter net income were -25,550 K.
